Evidence map›Paper›PMID 33840320›Full record

ArticleDrug delivery2021

Development of omega-3 loxoprofen-loaded nanoemulsion to limit the side effect associated with NSAIDs in treatment of tooth pain.

Khaled M Hosny, Amal M Sindi, Hala M Alkhalidi, Mallesh Kurakula, Amira H Hassan, Rana B Bakhaidar, Walaa A Abualsunun, Alshaimaa M Almehmady, Ahmed Khames, Waleed Y Rizg and 3 more

Open access · goldAbstract read
In one paragraph

Article in Drug delivery, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Khaled M HosnyDepartment of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.ORCID https://orcid.org/0000-0002-4904-1378
Amal M SindiOral Diagnostic Science Department, Faculty of Dentistry, King Abdulaziz University, Jeddah, Saudi Arabia.
Hala M AlkhalidiDepartment of Clinical Pharmacy, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
Mallesh KurakulaDepartment of Biomedical Engineering, The Herff College of Engineering, Memphis, TN, USA.
Amira H HassanDepartment of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt.
Rana B BakhaidarDepartment of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
Walaa A AbualsununDepartment of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
Alshaimaa M AlmehmadyDepartment of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
Ahmed KhamesDepartment of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt.
Waleed Y RizgDepartment of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
Rasha A KhallafDepartment of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt.
Nabil K AlruwailiDepartment of Pharmaceutics, Faculty of Pharmacy, Jouf University, Skaka, Saudi Arabia.
Nabil A AlhakamyDepartment of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.ORCID https://orcid.org/0000-0002-3826-1519
King Abdulaziz University · SABeni-Suef University · EGJouf University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The majority of newly developed drugs need to be incorporated with delivery systems to maximize their effect and minimize side effects. Nanoemulsions (NEs) are one type of delivery system that helps to improve the solubility and dissolution of drugs, attempting to enhance their bioavailability and onset of action. The objective of this investigation was to develop an omega-3 oil-based NE loaded with loxoprofen (LXP) to enhance its dissolution,

Indexed as

Administration, TopicalAnimalsAnti-Inflammatory Agents, Non-SteroidalChemistry, PharmaceuticalDrug Delivery SystemsDrug LiberationEmulsionsFatty Acids, Omega-3MaleNanoparticlesPhenylpropionatesRatsSheepSkin AbsorptionSolubilitySurface-Active AgentsAnti-Inflammatory Agents, Non-SteroidalEmulsionsFatty Acids, Omega-3loxoprofenPhenylpropionatesSurface-Active Agentsex vivo permeationLoxoprofennanoemulsionsomega-3 oilulcer index

Identifiers

PMID33840320
PMCPMC8057080
OpenAlexW3155895270

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.